Katphala: Benefits, Evidence & Safety

TL;DR

Katphala is the stem bark (and fruit) of Myrica esculenta, a Himalayan tree Ayurveda traditionally uses for cough, bronchitis, and asthma. No human trials were identified in the reviews. Animal studies show anti-inflammatory effects in paw-swelling models, and lab work confirms antioxidant and antimicrobial activity. All modern evidence is preclinical: traditional respiratory use is not yet clinically supported.

What it is

Katphala is the stem bark of Myrica esculenta Buch.-Ham. ex D. Don (family Myricaceae), a tree of the Himalayan region also known as box myrtle or kaphal (MDPI Plants review). The Ayurvedic Pharmacopoeia of India includes monographs for both Katphala fruit and Katphala stem bark under this botanical name (API, Part I, Vol. III, as cited in the IJAMSCR review). The bark is rich in phenolic compounds and tannins, with gallic acid, myricanol, myricanone, and epigallocatechin gallate-type constituents reported (IJAMSCR review).

Traditional use

In Ayurveda, Katphala (Myrica esculenta) is traditionally known for anti-asthmatic properties and is used in Tamaka Shvasa, the classical correlate of bronchial asthma (IJAMSCR review). The bark is widely used in Ayurvedic formulations including churnas, asava-arishta, oils, and tablets (same review). Folk practice includes applying bark paste on the chest for relief of cough and bronchitis, and using the fruits in foods such as syrups and jams in the Himalayas (nutritional/elemental analysis, J. Biol. Chem. Chron.). These are traditional claims, not clinical proof: no human trials were found.

What modern research says

Inflammation (animal)

A comprehensive peer-reviewed review tabulates animal anti-inflammatory data: methanolic leaf extract at 200 mg/kg orally showed significant activity in the carrageenan-induced rat paw edema model, and ethyl acetate and aqueous bark extracts at 100–200 mg/kg showed significant anti-inflammatory potential in carrageenan- and histamine-induced paw edema in Wistar rats (MDPI Plants review). These are acute-inflammation animal models only; they say nothing about chronic inflammatory disease in humans.

Asthma and allergy (preclinical)

Experimental research has reported anti-asthmatic, anti-allergic, and anti-inflammatory properties for Myrica esculenta (IJAMSCR review). These are laboratory and animal findings cited in a review of Katphala's use in bronchial asthma; no randomized human trials of Katphala for asthma were identified. Traditional respiratory use therefore remains unconfirmed by clinical research.

Antioxidant and antimicrobial activity (in vitro)

In vitro and animal work summarized in the MDPI review reports antioxidant activity and antimicrobial potential of bark and fruit extracts against bacteria and fungi (MDPI Plants review). The leaves contain flavonoids, tannins, diarylheptanoids, and phenolic acids associated in preclinical models with various biological activities, but these compound-level findings are not evidence of clinical benefit (same review).

Safety & contraindications

The cited reviews report no published human safety studies of Katphala and no reliable data on safety in pregnancy or breastfeeding, or on interactions with medications (MDPI Plants review; IJAMSCR review). Safety data is limited: talk to a clinician before use, especially if you have asthma or another respiratory condition: herbal preparations are not a substitute for prescribed asthma treatment, and delaying effective treatment for breathing difficulty can be dangerous.

FAQs

What is Katphala?

Katphala is the Ayurvedic name for the stem bark (and fruit) of Myrica esculenta, a Himalayan tree in the Myricaceae family. The Ayurvedic Pharmacopoeia of India includes monographs for both parts (MDPI Plants review; API, Part I, Vol. III). The bark is rich in phenolic compounds and tannins, including gallic acid, myricanol, and myricanone, and the fruit is eaten in the Himalayas in syrups and jams.

Does Katphala help with asthma?

Traditionally Katphala is used for Tamaka Shvasa (bronchial asthma), and preclinical research cited in a review of its asthma use reports anti-asthmatic, anti-allergic, and anti-inflammatory properties (IJAMSCR review). But no human trials were identified, so there is no clinical evidence it helps asthma in people. Do not replace prescribed asthma treatment with it: delaying effective treatment for breathing difficulty can be dangerous.

Is there any human evidence for Katphala?

None was found. All modern evidence, anti-inflammatory, antioxidant, antimicrobial, and anti-asthmatic, comes from animal, in vitro, or ex vivo studies summarized in peer-reviewed reviews (MDPI Plants review). For example, animal studies show anti-inflammatory activity in paw-swelling models. Human trials are still needed before any clinical benefit can be claimed.

Which part of the plant is used?

The Ayurvedic Pharmacopoeia of India covers both the fruit and the stem bark of Myrica esculenta; traditional respiratory preparations most often use the bark (API, Part I, Vol. III; IJAMSCR review). The bark appears in churnas, asava-arishta, oils, and tablets, and folk practice includes applying bark paste to the chest for cough and bronchitis. In the Himalayas the fruits are also eaten as syrups and jams.

Is Katphala safe?

No published human safety studies exist, and there are no reliable data on pregnancy, breastfeeding, or drug interactions. Safety data is limited: talk to a clinician before use, and never substitute it for prescribed respiratory medication. Herbal preparations are not a substitute for prescribed asthma treatment, and delaying effective treatment for breathing difficulty can be dangerous.

Sources

Disclaimer

This article is for educational purposes only and is not medical advice. Herbal products can interact with medications and are not suitable for everyone. Talk to a qualified healthcare practitioner before use — especially if you are pregnant, breastfeeding, managing a medical condition, or taking prescription medicines.